Jinfei Fu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Jinfei Fu has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Changwu Wu
University of Leipzig
1 shared publicationHao Wu
University of Missouri School of Medicine
1 shared publicationJuyu Tang
Central South University
1 shared publication- Juyu Tang
Department of Orthopedics, Xiangya Hospital, Central South University, Changsha, China
1 shared publication - Laiyu Xu
Department of Orthopedics, School of Medicine, The First Affiliated Hospital of Zhejiang University, Hangzhou, China
1 shared publication - Liming Qing
Department of Orthopedics, Xiangya Hospital, Central South University, Changsha, China
1 shared publication
Latest Publications
- Open Access
- 28 August 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (35) , e50476
The global perspective on the evolution of nurse-related research in primary malignant bone tumors from 2004 to 2025
Background: Primary malignant bone tumors, as diseases that mostly occur in adolescence, seriously affect all aspects of the lives of patients and their families. Effective bone tumor nursing is essential to maintain or improve patients’ quality of life. Consequently, investigating bone tumor nursing is of utmost importance. This study aimed to provide a comprehensive, up-to-date synthesis of all published bone tumor nursing research articles and predict future areas of research and emerging trends. Methods: A bibliometric analysis was conducted using the Web of Science Core Collection to identify and analyze nursing research publications on primary malignant bone tumors from January 1, 2004, to September 12, 2025. The analysis and visualization were performed using various scientometric tools. Key characteristics of the publications, including country of origin, institutions, authors, journals, keywords, and references, were thoroughly examined. Results: A total of 686 studies were included in the analysis, with 5376 authors, 70 countries, and 1422 institutions publishing research focused on nurse-related studies in primary malignant bone tumors. The United States and Memorial Sloan Kettering Cancer Center led the lists of publications. The most prolific cited and co-cited authors were Oeffinger, Kevin C, and Bacci, G, respectively. Pediatric Blood & Cancer published the most articles, whereas Journal of Clinical Oncology was the most frequently cited journal. The analysis of keyword co-occurrence and literature co-citation identified several emerging hotspots and trends in the field of primary malignant bone tumor nursing, including prognostic evaluation, clinical intervention, and subtype-targeted nursing care. Conclusion: In recent years, the advancement in nurse-related research in primary malignant bone tumors has accelerated rapidly. A comprehensive bibliometric analysis was utilized to verify the prominent areas of investigation and anticipate future research directions, with the aim of providing valuable insights and recommendations for future studies.
- 28 August 2026
- Published by Wolters Kluwer Health in Medicine
- Vol. 105 (35) , e50476
Open AccessThe global perspective on the evolution of nurse-related research in primary malignant bone tumors from 2004 to 2025
Background: Primary malignant bone tumors, as diseases that mostly occur in adolescence, seriously affect all aspects of the lives of patients and their families. Effective bone tumor nursing is essential to maintain or improve patients’ quality of life. Consequently, investigating bone tumor nursing is of utmost importance. This study aimed to provide a comprehensive, up-to-date synthesis of all published bone tumor nursing research articles and predict future areas of research and emerging trends. Methods: A bibliometric analysis was conducted using the Web of Science Core Collection to identify and analyze nursing research publications on primary malignant bone tumors from January 1, 2004, to September 12, 2025. The analysis and visualization were performed using various scientometric tools. Key characteristics of the publications, including country of origin, institutions, authors, journals, keywords, and references, were thoroughly examined. Results: A total of 686 studies were included in the analysis, with 5376 authors, 70 countries, and 1422 institutions publishing research focused on nurse-related studies in primary malignant bone tumors. The United States and Memorial Sloan Kettering Cancer Center led the lists of publications. The most prolific cited and co-cited authors were Oeffinger, Kevin C, and Bacci, G, respectively. Pediatric Blood & Cancer published the most articles, whereas Journal of Clinical Oncology was the most frequently cited journal. The analysis of keyword co-occurrence and literature co-citation identified several emerging hotspots and trends in the field of primary malignant bone tumor nursing, including prognostic evaluation, clinical intervention, and subtype-targeted nursing care. Conclusion: In recent years, the advancement in nurse-related research in primary malignant bone tumors has accelerated rapidly. A comprehensive bibliometric analysis was utilized to verify the prominent areas of investigation and anticipate future research directions, with the aim of providing valuable insights and recommendations for future studies.
- Open Access
- 22 June 2022
- Published by Springer Nature in Research Square
A Human Pan-Cancer System Analysis of Regulator of Chromatin Condensation 2
Regulation of chromosome condensation 2 (RCC2) is associated with the cell cycle and is a crucial regulator of the chromatin condensation 1 (RCC1) family. The members of this family were normally regulators in the process of DNA replication and nucleocytoplasmic transport. RCC2 overexpression may lead to tumor formation and poor prognosis in some tumors including breast cancer and lung adenocarcinoma. However, the possible role of RCC2 in tumor formation and its prognostic function remains unclear. In this study, expression analysis from databases including The Cancer Genome Atlas (TCGA) and Clinical Proteomic Tumor Analysis Consortium (CPTAC) were combined to perform the first integrative and comprehensive analysis of RCC2 in human pan-cancer. RCC2 was high expressed in most tumors which may lead to poor prognosis. RCC2 expression was associated with immune/stromal infiltration, immune checkpoints, tumor mutational burden, and microsatellite instability. Thus, RCC2 could be a novel biomarker for prognosis and a promising cancer therapy target.
- 22 June 2022
- Published by Springer Nature in Research Square
Open AccessA Human Pan-Cancer System Analysis of Regulator of Chromatin Condensation 2
Regulation of chromosome condensation 2 (RCC2) is associated with the cell cycle and is a crucial regulator of the chromatin condensation 1 (RCC1) family. The members of this family were normally regulators in the process of DNA replication and nucleocytoplasmic transport. RCC2 overexpression may lead to tumor formation and poor prognosis in some tumors including breast cancer and lung adenocarcinoma. However, the possible role of RCC2 in tumor formation and its prognostic function remains unclear. In this study, expression analysis from databases including The Cancer Genome Atlas (TCGA) and Clinical Proteomic Tumor Analysis Consortium (CPTAC) were combined to perform the first integrative and comprehensive analysis of RCC2 in human pan-cancer. RCC2 was high expressed in most tumors which may lead to poor prognosis. RCC2 expression was associated with immune/stromal infiltration, immune checkpoints, tumor mutational burden, and microsatellite instability. Thus, RCC2 could be a novel biomarker for prognosis and a promising cancer therapy target.